Amag Pharmaceuticals (33)

Browse by Contract Category

Contracts

Supplemental Indenture, dated as of November 16, 2020, among AMAG Pharmaceuticals, Inc., Covis Finco S. r.l. and Wilmington Trust, National Association (Filed With SEC on November 17, 2020)
License and Commercialization Agreement, effective as of July 23, 2020, by and between AMAG Pharmaceuticals, Inc. and Norgine B.V (Filed With SEC on November 6, 2020)
Agreement and Plan of Merger, dated as of October 1, 2020, by and among AMAG Pharmaceuticals, Inc., Covis Group S. r.l. and Covis Mergerco, Inc (Filed With SEC on October 1, 2020)
Termination Agreement, dated (Filed With SEC on July 27, 2020)
Separation Letter between Julie Krop and AMAG Pharmaceuticals, Inc., dated March 3, 2020 (Filed With SEC on May 11, 2020)
Lease Agreement, dated as of June 10, 2013, by and between AMAG Pharmaceuticals, Inc. and BP BAY COLONY LLC and as amended through December 2019 (Filed With SEC on March 6, 2020)
Termination of Distribution and Supply Agreement, dated as of August 6, 2019, by and between AMAG Pharmaceuticals, Inc. and Prasco, LLC (Filed With SEC on November 1, 2019)
Supplemental Indenture, dated as of November 16, 2020, between AMAG Pharmaceuticals, Inc. and Wilmington Trust, National Association (Filed With SEC on November 17, 2020)
Supplemental Indenture, dated as of November 16, 2020, among AMAG Pharmaceuticals, Inc., Covis Finco S. r.l. and Wilmington Trust, National Association (Filed With SEC on November 17, 2020)
Supplemental Indenture, dated as of November 16, 2020, between AMAG Pharmaceuticals, Inc. and Wilmington Trust, National Association (Filed With SEC on November 17, 2020)
Asset Purchase Agreement, dated May 21, 2020, by and between AMAG Pharmaceuticals, Inc. and Millicent Pharma Limited (Filed With SEC on May 22, 2020)
Form of Restricted Stock Unit Agreement - Non-Plan Inducement Grant (Filed With SEC on May 11, 2020)
Form of Non-Qualified Stock Option Agreement - Non-Plan Inducement Grant (Filed With SEC on May 11, 2020)
Employment Agreement by and between AMAG Pharmaceuticals, Inc. and Scott Myers effective as of April 28, 2020 (Filed With SEC on April 28, 2020)
Form of Restricted Stock Unit Agreement (Deferred) for Non-Employee Directors under AMAG Pharmaceuticals, Inc.s 2019 Equity Incentive Plan (Filed With SEC on March 6, 2020)
Form of Employment Agreement between AMAG Pharmaceuticals, Inc. and each of its executive officers (other than William K. Heiden) (Filed With SEC on March 6, 2020)
Form of Restricted Stock Unit Agreement for Non-Employee Directors under AMAG Pharmaceuticals, Inc.s 2019 Equity Incentive Plan (Filed With SEC on March 6, 2020)
Form of Restricted Stock Unit Agreement for AMAG Pharmaceuticals, Inc. Employees under AMAG Pharmaceuticals, Inc.s 2019 Equity Incentive Plan (Filed With SEC on March 6, 2020)
Form of Non-Qualified Stock Option Agreement for AMAG Pharmaceuticals, Inc. Employees under AMAG Pharmaceuticals, Inc.s 2019 Equity Incentive Plan (Filed With SEC on March 6, 2020)
Form of Incentive Stock Option Agreement for AMAG Pharmaceuticals, Inc. Employees under AMAG Pharmaceuticals, Inc.s 2019 Equity Incentive Plan (Filed With SEC on March 6, 2020)
Description of AMAG Pharmaceuticals, Inc. Securities Registered Pursuant to Section 12 of the Securities and Exchange Act of 1934 (Filed With SEC on March 6, 2020)
Form of Non-Qualified Stock Option Agreement for Non-Employee Directors under AMAG Pharmaceuticals, Inc.s 2019 Equity Incentive Plan (Filed With SEC on March 6, 2020)
Separation Letter between William Heiden and AMAG Pharmaceuticals, Inc., dated January 7, 2020 (Filed With SEC on January 9, 2020)
Manufacturing Services Agreement, dated as of June 1, 2018, by and between AMAG Pharmaceuticals, Inc. and Lonza Ltd (Filed With SEC on November 1, 2019)
Supply Agreement, dated as of December 20, 2018, by and between AMAG Pharmaceuticals, Inc. and Ypsomed AG (Filed With SEC on November 1, 2019)
Commercial Supply Agreement, dated as of June 10, 2016, by and between AMAG Pharmaceuticals, Inc. (as assignee from Palatin Technologies, Inc.) and Catalent Belgium S.A (Filed With SEC on November 1, 2019)
Settlement Agreement, dated October 8, 2019, by and among AMAG Pharmaceuticals, Inc., Caligan Partners LP, Caligan Partners CV II LP, David E. Johnson and Paul Fonteyne (Filed With SEC on October 8, 2019)
Product Supply Agreement, dated as of June 1, 2017, by and between AMAG Pharmaceuticals, Inc. and Pfizer, Inc (Filed With SEC on May 8, 2019)
Form of Restricted Stock Unit Agreement (Deferred) for Non-Employee Directors under AMAG Pharmaceuticals, Inc.s Fourth Amended and Restated 2007 Equity Incentive Plan (Filed With SEC on May 8, 2019)
AMAG Pharmaceuticals, Inc. Non-Employee Directors Deferred Compensation Program (Filed With SEC on May 8, 2019)
AMAG Pharmaceuticals, Inc. Non-Employee Directors Compensation Policy (Filed With SEC on May 8, 2019)
Contract Manufacturing Agreement, dated September 1, 2018, by and between AMAG Pharmaceuticals, Inc. and Fresenius Kabi Austria GmbH (Certain confidential information contained in... (Filed With SEC on March 1, 2019)
AMAG Pharmaceuticals, Inc. Long-Term Incentive Plan (included as Exhibit A to the Form of Award Notice under the AMAG Pharmaceuticals, Inc. Long-term Incentive Plan filed as... (Filed With SEC on March 1, 2019)